Literature DB >> 12391211

Long-term maintenance of virus-specific effector memory CD8+ T cells in the lung airways depends on proliferation.

Robert J Hogan1, Linda S Cauley, Kenneth H Ely, Tres Cookenham, Alan D Roberts, Jean W Brennan, Simon Monard, David L Woodland.   

Abstract

Recent studies have shown that virus-specific effector memory T cells can be recovered from the lung airways long after clearance of a respiratory virus infection. These cells are thought to play an important role in the recall response to secondary viral infection. It is currently unclear whether these cells actually persist at this site or are maintained by continual proliferation and recruitment. In this study, we have analyzed the mechanisms underlying the persistence of memory CD8(+) T cells in the lung airway lumina following recovery from a respiratory virus infection. The data identify two distinct populations of memory cells. First, a large population Ag-specific CD8(+) T cells is deposited in the airways during the acute response to the virus. These cells persist in a functional state for several weeks with minimal further division. Second, a smaller population of Ag-specific CD8(+) T cells is maintained in the lung airways by homeostatic proliferation and migration to lung airways after viral clearance. This rate of proliferation is identical to that observed in the spleen, suggesting that these cells may be recent immigrants from the lymphoid organs. These data have significant implications for vaccines designed to promote cellular immunity at mucosal sites such as the lung.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391211     DOI: 10.4049/jimmunol.169.9.4976

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  T cell memory in the lung airways.

Authors:  David L Woodland; Iain Scott
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7.

Authors:  Heike Unsoeld; Hanspeter Pircher
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Immunity and protection, the unfolding of a tale.

Authors:  Maurizio Zanetti
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 5.  Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.

Authors:  Yoshiko Mizukawa; Tetsuo Shiohara
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

Review 6.  Migration, maintenance and recall of memory T cells in peripheral tissues.

Authors:  David L Woodland; Jacob E Kohlmeier
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

7.  Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus.

Authors:  Thomas Gebhardt; Linda M Wakim; Liv Eidsmo; Patrick C Reading; William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

Review 8.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

9.  Polarized alloantigen presentation by airway epithelial cells contributes to direct CD8+ T cell activation in the airway.

Authors:  Daniel Kreisel; Jiaming Lai; Steven B Richardson; Aida Ibricevic; Ruben G Nava; Xue Lin; Wenjun Li; Christopher G Kornfeld; Mark J Miller; Steven L Brody; Andrew E Gelman; Alexander S Krupnick
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06       Impact factor: 6.914

Review 10.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

Authors:  Jeffrey L Curtis; Christine M Freeman; James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2007-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.